It means the risk profile is nowhere near as casual as the marketing makes it sound
Unlike the pain of an injury or arthritis, FM pain is a whole-body, often unrelenting condition that increases the risks for SUDs
The table covers five factors: pharmacy licensing, provider credentials, the initial assessment, ongoing monitoring, and cost transparency
We received the application for a new device category for transitional pass-through payment status for the VersaVue TM Single-Use Flexible Cystoscope on February 11, 2025, which is within 3 years of the date of the initial FDA marketing authorization
Symptoms, especially for men, normally start to present around age 4060 and include joint pain, fatigue, abdominal pain, and impotence
This transparent, flat-rate pricing model means your dose may increase as your therapy advances, but your monthly cost remains predictable